Literature DB >> 25774380

An ex vivo Model of HIV-1 Infection in Human Lymphoid Tissue and Cervico-vaginal Tissue.

Andrea Introini1, Christophe Vanpouille1, Jean Charles Grivel1, Leonid Margolis1.   

Abstract

Human tissue explants are a valuable tool to study the interactions between host and infectious agents. They reliably mimic many important aspects of tissue cytoarchitecture and functions and allow us the investigation of the mechanisms of microbial pathogenesis under controlled laboratory conditions. One of the advantages of this system is that, unlike isolated cells, infection of tissue blocks with HIV-1 does not require exogenous stimulation with mitogens or activating factors. Here we describe a protocol to infect with HIV-1 human lymphoid tissue from tonsils and cervico-vaginal tissue and maintain them in culture in a non-polarized setting. These ex vivo infected tissues can be used as fruitful models to study HIV-1 pathogenesis and HIV-1 vaginal transmission, respectively, as well as an efficient platform for testing anti-HIV therapeutic and preventative strategies.

Entities:  

Year:  2014        PMID: 25774380      PMCID: PMC4358795          DOI: 10.21769/bioprotoc.1047

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  9 in total

1.  Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin.

Authors:  Christophe Vanpouille; Andrea Lisco; Andrea Introini; Jean-Charles Grivel; Arshi Munawwar; Melanie Merbah; Raymond F Schinazi; Marco Derudas; Christopher McGuigan; Jan Balzarini; Leonid Margolis
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

2.  Cervico-vaginal tissue ex vivo as a model to study early events in HIV-1 infection.

Authors:  Melanie Merbah; Andrea Introini; Wendy Fitzgerald; Jean-Charles Grivel; Andrea Lisco; Christophe Vanpouille; Leonid Margolis
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

3.  Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.

Authors:  Jeffrey Pudney; Alison J Quayle; Deborah J Anderson
Journal:  Biol Reprod       Date:  2005-08-10       Impact factor: 4.285

Review 4.  Use of human mucosal tissue to study HIV-1 pathogenesis and evaluate HIV-1 prevention modalities.

Authors:  Charlene S Dezzutti; Florian Hladik
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

5.  A highly sensitive and dynamic immunofluorescent cytometric bead assay for the detection of HIV-1 p24.

Authors:  Angélique Biancotto; Beda Brichacek; Silvia S Chen; Wendy Fitzgerald; Andrea Lisco; Christophe Vanpouille; Leonid Margolis; Jean-Charles Grivel
Journal:  J Virol Methods       Date:  2009-01-06       Impact factor: 2.014

6.  Use of human tissue explants to study human infectious agents.

Authors:  Jean-Charles Grivel; Leonid Margolis
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

7.  HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model.

Authors:  E Saba; J-C Grivel; C Vanpouille; B Brichacek; W Fitzgerald; L Margolis; A Lisco
Journal:  Mucosal Immunol       Date:  2010-02-10       Impact factor: 7.313

8.  Interleukin-7 facilitates HIV-1 transmission to cervico-vaginal tissue ex vivo.

Authors:  Andrea Introini; Christophe Vanpouille; Andrea Lisco; Jean-Charles Grivel; Leonid Margolis
Journal:  PLoS Pathog       Date:  2013-02-07       Impact factor: 6.823

9.  Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle.

Authors:  E Saba; M Origoni; G Taccagni; D Ferrari; C Doglioni; A Nava; A Lisco; J-C Grivel; L Margolis; G Poli
Journal:  Mucosal Immunol       Date:  2013-02-06       Impact factor: 7.313

  9 in total
  9 in total

1.  Innate Invariant NKT Cell Recognition of HIV-1-Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion.

Authors:  Dominic Paquin-Proulx; Anna Gibbs; Susanna M Bächle; Antonio Checa; Andrea Introini; Edwin Leeansyah; Craig E Wheelock; Douglas F Nixon; Kristina Broliden; Annelie Tjernlund; Markus Moll; Johan K Sandberg
Journal:  J Immunol       Date:  2016-08-01       Impact factor: 5.422

2.  MZC Gel Inhibits SHIV-RT and HSV-2 in Macaque Vaginal Mucosa and SHIV-RT in Rectal Mucosa.

Authors:  Giulia Calenda; Guillermo Villegas; Patrick Barnable; Claudia Litterst; Keith Levendosky; Agegnehu Gettie; Michael L Cooney; James Blanchard; José A Fernández-Romero; Thomas M Zydowsky; Natalia Teleshova
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

3.  Seminal plasma induces inflammation and enhances HIV-1 replication in human cervical tissue explants.

Authors:  Andrea Introini; Stéphanie Boström; Frideborg Bradley; Anna Gibbs; Axel Glaessgen; Annelie Tjernlund; Kristina Broliden
Journal:  PLoS Pathog       Date:  2017-05-19       Impact factor: 6.823

4.  Vaginal Lactobacillus Inhibits HIV-1 Replication in Human Tissues Ex Vivo.

Authors:  Rogers A Ñahui Palomino; Sonia Zicari; Christophe Vanpouille; Beatrice Vitali; Leonid Margolis
Journal:  Front Microbiol       Date:  2017-05-19       Impact factor: 5.640

5.  Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice.

Authors:  Jessica Katy Skelton; Ana Maria Ortega-Prieto; Steve Kaye; Jose Manuel Jimenez-Guardeño; Jane Turner; Michael H Malim; Greg J Towers; Marcus Dorner
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

6.  Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue.

Authors:  Laura Else; Sujan D Penchala; Azure-Dee Pillay; Thabiso B Seiphetlo; Limakatso Lebina; Christian Callebaut; Suks Minhas; Roland Morley; Tina Rashid; Neil Martinson; Julie Fox; Saye Khoo; Carolina Herrera
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

7.  MAIT cells reside in the female genital mucosa and are biased towards IL-17 and IL-22 production in response to bacterial stimulation.

Authors:  A Gibbs; E Leeansyah; A Introini; D Paquin-Proulx; K Hasselrot; E Andersson; K Broliden; J K Sandberg; A Tjernlund
Journal:  Mucosal Immunol       Date:  2016-04-06       Impact factor: 7.313

8.  Complement opsonization of HIV affects primary infection of human colorectal mucosa and subsequent activation of T cells.

Authors:  Esaki M Shankar; Sofia Nyström; Pradyot Bhattacharya; Rada Ellegård; Mohammad Khalid; Cecilia Svanberg; Melissa Govender; Åsa V Keita; Johan D Söderholm; Pär Myrelid; Marie Larsson
Journal:  Elife       Date:  2020-09-02       Impact factor: 8.140

9.  HIV-1 infection of CD4 T cells impairs antigen-specific B cell function.

Authors:  Sheetal Kaw; Swetha Ananth; Nikolaos Tsopoulidis; Katharina Morath; Bahar M Coban; Ralph Hohenberger; Olcay C Bulut; Florian Klein; Bettina Stolp; Oliver T Fackler
Journal:  EMBO J       Date:  2020-11-04       Impact factor: 14.012

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.